LAMTOR5-AS1 regulates the interaction between NRF2 and Kelch-like ECH-associated protein 1 (KEAP1) to inhibit NRF2 transcriptional activity under chemotherapeutic drugs treatment, which finally results in an increase in drug sensitivity in osteosarcoma [70]. The gene discussed is NFE2L2; the disease is osteosarcoma.